CHI3L1 and interstitial lung disease: Schoneveld et al. (43) retrospectively analyzed serum CHI3L1 levels in patients with coronavirus disease 2019 (COVID-19), chronic obstructive pulmonary disease, and unrelated interstitial lung disease and found that CHI3L1 upregulation in patients was strongly associated with the level of inflammation.